SEAS study News
Most Popular SEAS study Story
FDA probes Vytorin cancer risk
Yesterday, a study appeared to clear statins of their possible link to cancer. But today, the FDA says it's Read more...
Latest Headlines
- September 19, 2008
- September 5, 2008
- September 3, 2008
- September 2, 2008
- September 2, 2008
- August 22, 2008
- August 1, 2008
- July 25, 2008
- July 22, 2008
- July 21, 2008
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
